[Use of the analeptin test in prognosis of phenothiazine therapy of patients with diseases of the schizophrenia group].
D014150:Antipsychotic Agents; D010640:Phenothiazines / Q000628:therapy*; D011379:Prognosis; D012559:Schizophrenia / Q000628:therapy*; D013566:Sympathomimetics
D014150:Antipsychotic Agents; D010640:Phenothiazines; D013566:Sympathomimetics; C031637:phenothiazine
PHENOTHIAZINES/therapy; SCHIZOPHRENIA/therapy; SYMPATHOMIMETICS